Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dyslipidemia

Free Subscription Articles published in Clin Cardiol Retrieve available abstracts of 13 articles: HTML format

Single Articles

May 2025
1. KURDZIEL J, Fedak A, Kawalec E, Miarka P, et al
   Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia-A Lipid Clinic Experience.
   Clin Cardiol. 2025;48:e70125.
   PubMed     Abstract available
   
   
   
2. KI YJ, Kim W, Lee KH, Han SJ, et al
   Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
   Clin Cardiol. 2025;48:e70138.
   PubMed     Abstract available
   
   
   December 2024
3. WU R, Su Y, Liao J, Shen J, et al
   Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early-Onset Coronary Atherosclerotic Disease.
   Clin Cardiol. 2024;47:e70066.
   PubMed     Abstract available
   
   
   September 2024
4. MAURY E, Brouyere S, Jansen M
   Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL-C Levels.
   Clin Cardiol. 2024;47:e24330.
   PubMed     Abstract available
   
   
   May 2024
5. TOLU-AKINNAWO OZ, Awoyemi T, Guzman RB, Naveed A, et al
   Olanzapine-induced cardiomyopathy: A mimicker of obesity cardiomyopathy?
   Clin Cardiol. 2024;47:e24278.
   PubMed     Abstract available
   
   
   November 2023
6. GAVINA C, Seabra-Carvalho D, Aguiar C, Anastassopoulou A, et al
   Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
   Clin Cardiol. 2023 Nov 6. doi: 10.1002/clc.24183.
   PubMed     Abstract available
   
   
   October 2023
7. BEATTY C, Richardson KP, Tran PMH, Satter KB, et al
   Multiplex analysis of inflammatory proteins associated with risk of coronary artery disease in type-1 diabetes patients.
   Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24143.
   PubMed     Abstract available
   
   
   
8. FALLAHZADEH A, Mehraban S, Mahmoodi T, Sheikhy A, et al
   Risk factor profile and outcomes of premature acute coronary syndrome after percutaneous coronary intervention: A 1-year prospective design.
   Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24170.
   PubMed     Abstract available
   
   
   August 2023
9. MA X, Zhang H, Tian Y, Wang Y, et al
   Mediating effect of depression on the association between cardiovascular disease and the risk of all-cause mortality: NHANES in 2005-2018.
   Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24103.
   PubMed     Abstract available
   
   
   June 2023
10. HUANG H, Leung KSK, Garg T, Mazzoleni A, et al
    Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.
    Clin Cardiol. 2023 Jun 1. doi: 10.1002/clc.24059.
    PubMed     Abstract available
    
    
    May 2023
11. ROMANO S, Minardi S, Patrizi G, Palama Z, et al
    Sport in ischemic heart disease: Focus on primary and secondary prevention.
    Clin Cardiol. 2023 May 28. doi: 10.1002/clc.24052.
    PubMed     Abstract available
    
    
    
12. ZHOU P, Huang L, Zhai M, Huang Y, et al
    Prognostic role and relationship of thyroid dysfunction and lipid profile in hospitalized heart failure patients.
    Clin Cardiol. 2023 May 25. doi: 10.1002/clc.24057.
    PubMed     Abstract available
    
    
    January 2023
13. PARK HB, Lee J, Hong Y, Byungchang S, et al
    Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23964.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.